News and Articles

A recent study 1 was undertaken to evaluate long-term effects of continuous glucose monitoring (CGM) versus capillary blood glucose monitoring (CBG) in adults living with insulin-treated type 2 diabetes (T2D)...

The Dexcom G7 Continuous Glucose Monitoring (CGM) System provides real-time glucose readings and is clinically proven to lower A1C and improve time in range (TIR). 1-5 To help achieve this...

As innovation and technology in healthcare evolve, Dexcom Continuous Glucose Monitoring (CGM) Systems have become more connected than ever, integrating with more than 80 health devices, wearables, tools, and apps...

Dexcom G7 is our most accessible and affordable glucose sensor ever, covered by most private insurers and many provincial health programs, making it easier for individuals on insulin to proactively...

A recent clinical study 1 found encouraging accuracy results for pregnant women who used the Dexcom G7 real-time Continuous Glucose Monitoring (rtCGM) System . The study followed 96 pregnant women...

The 2023 Preechasuk study of adults with type 1 diabetes (T1D) who switched from an intermittently scanned continuous glucose monitoring (isCGM) device to Dexcom G7 real-time Continuous Glucose Monitoring (rtCGM)...